The need for better evidence to evaluate the health & economic benefits of India’s Rashtriya Swasthya Bima Yojana

Arindam Nandi, E. Phoebe Holtzman, Anup Malani, Ramanan Laxminarayan

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

In this review the existing evidence on the impact of Rashtriya Swasthya Bima Yojana (RSBY) is discussed in the context of international literature available on health insurance. We describe potential pathways through which health insurance can affect health and economic outcomes, discuss evidence from other developing countries, and identify potential biases and inconsistencies in existing studies on RSBY impact. Given the relatively recent introduction of RSBY, lack of quality, verifiable data on utilization patterns, and the absence of reliable evaluation studies, there is a need to exercise caution while assessing the merits of the programme. Considering the enormous potential and cost of the programme, we emphasize the need for a rigorous impact evaluation of RSBY. It will not only help capture the real impact of the scheme, but may also be able to estimate the extent of systemic inefficiencies at the level of the consumer.

Original languageEnglish (US)
Pages (from-to)383-390
Number of pages8
JournalIndian Journal of Medical Research
Volume142
Issue numberOCTOBER
DOIs
StatePublished - Oct 2015
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine

Keywords

  • Financial risk protection
  • Impact evaluation
  • RSBY
  • Social health insurance

Fingerprint

Dive into the research topics of 'The need for better evidence to evaluate the health & economic benefits of India’s Rashtriya Swasthya Bima Yojana'. Together they form a unique fingerprint.

Cite this